Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 89

The DOI matches its Crossref record.

L-Carnitine for Acute Valproic Acid Overdose: A Systematic Review of Published Cases

Perrott, Jerrold, Murphy, Nancy G, Zed, Peter J · 2010 · Annals of Pharmacotherapy

Abstract

Objective: To review the evidence supporting the efficacy and safety of l-carnitine in the management of acute valproic acid overdose. DATA SOURCES: MEDLINE (1950–May 2010), EMBASE (1980–May 2010), and Google Scholar (to May 2010) were searched, using the terms carnitine, valproic acid, and carnitine for valproic acid overdose. Reference citations from identified publications were reviewed. Study Selection and Data Extraction: Full-text publications evaluating the use of l-carnitine for management of valproic acid overdose in humans were sought. All studies, regardless of design, case series, and case reports reporting efficacy or safety endpoints were included. All languages were included. Two authors extracted primary data elements including patient demographics, presenting features, clinical management, and outcomes. Data Synthesis: Seven articles discussing 8 patients and 1 reporting safety data from records of 674 patients were reviewed. Reports covered both pediatric and adult patients with acute exposures to valproic acid mono- and polydrug overdose who were treated with various regimens of l-carnitine. All patients recovered clinically and no adverse effects were noted. Conclusions: Published evidence of the efficacy and safety of l-carnitine as an antidote for acute valproic acid overdose is limited. Based on the available evidence, it is reasonable to consider l-carnitine for patients with acute overdose of valproic acid who demonstrate decreased level of consciousness. We recommend intravenous administration of 100 mg/kg once, followed by infusions of 50 mg/kg (to a maximum of 3 g per dose) every 8 hours thereafter, continuing until ammonia levels are decreasing (if they were elevated initially) and the patient demonstrates signs of clinical improvement or until adverse events associated with l-carnitine occur.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1345/aph.1p135

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 18

  1. 10.34024/rnc.2008.v16.8650 · DOI
  2. 10.2165/00023210-200216100-00004 · DOI · Paper page
  3. 10.1081/CLT-120014645 · DOI · Paper page
  4. 10.1186/cc3742 · DOI
  5. 10.3109/15563650903438566 · DOI · Paper page
  6. Spiller HA, 2000, Clin Toxicol, 38, 755
  7. IshikuraH, MatsuoN, MatsubaraM. Levels of evidence. In: Oxford Centre for Evidence Based Medicine (March 2009). Valproic acid overdose and L-carnitine therapy. J Anal Toxicol 1996;20:55-8. · DOI
  8. MurakamiK, SugimotoT, WooM. Effect of L-carnitine supplementation on acute valproate intoxication. Epilepsia 1996;37:687-9. · DOI
  9. 10.1016/j.annfar.2003.11.018 · DOI
  10. 10.1177/0960327107087799 · DOI
  11. 10.1016/j.ajem.2007.06.020 · doi:10.1016/j.ajem.2007.06.020
  12. 10.1016/j.ajem.2007.07.032 · doi:10.1016/j.ajem.2007.07.032
  13. 10.1016/j.ajem.2005.02.015 · doi:10.1016/j.ajem.2005.02.015
  14. BrassEP, AdlerS, SietsemaKE. Intravenous L-carnitine increases carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis 2001;37:1018-28. DOI 10.1053/ajkd.2001.23647 · DOI
  15. CrucianiRA, DvorkinE, HomelP. Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study. J Pain Symptom Manage 2006;32:551-9. DOI 10.1016/j.jpainsymman.2006.09.001 · DOI
  16. 10.1016/j.pharmthera.2008.08.008 · DOI
  17. GoldfrankLR, NelsonLS, HowlandMA, LewinNA, FlomenbaumNE, HoffmanRS, eds. Goldfrank's toxicologic emergencies. 8th ed. New York: McGraw-Hill, 2006.
  18. OlsenKR, BenowitzNL, BlancPD, eds. Poisoning and drug overdose. 5th ed. New York: McGraw-Hill, 2006.

Cited by

See all 89

Metadata

Authors
Perrott, J., Murphy, N. G., & Zed, P. J.
Affiliations
  • Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; now, Clinical Pharmacy Specialist—Critical Care, Royal Columbian Hospital, New Westminster, BC, Canada
  • IWK Regional Poison Centre; Emergency Physician, Department of Emergency Medicine, Capital Health; Assistant Professor, Department of Emergency Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
  • Department of Pharmacy, and Pharmacotherapeutic Specialist, Emergency Medicine, Queen Elizabeth II Health Sciences Centre; Associate Professor, College of Pharmacy, and Department of Emergency Medicine, Dalhousie University
Venue
Annals of Pharmacotherapy
Published
2010-06-29
Volume
44
Issue
7-8
Pages
1287-1293
ISSN
  • 1060-0280
  • 1542-6270
Cited by
89
References
0
Language
en
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: L-Carnitine for Acute Valproic Acid Overdose: A Systematic Review of Published Cases. https://app.cochat.ai/papers/10.1345/aph.1p135
The paper
Perrott, J., Murphy, N. G., & Zed, P. J. (2010). L-Carnitine for Acute Valproic Acid Overdose: A Systematic Review of Published Cases. Annals of Pharmacotherapy. https://doi.org/10.1345/aph.1p135

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.